For weight management indications, dose adjustments consider weight loss trajectory, tolerability, and plateau effects
doi: 10.3389/fcdhc.2023.1293926 Received 13 September 2023 Accepted 16 November 2023 Published 08 December 2023 Volume 4 - 2023 Edited by Azra Durak-Nalbantic, Clinical Center University of Sarajevo, Bosnia and Herzegovina Reviewed by Edin Begic, Sarajevo School of Science and Technology, Bosnia and Herzegovina Updates Copyright 2023 Ferhatbegovi, Mri and Maci-Dankovi
Coffee: Moderate intake linked to increased GLP-1 secretion
"GIP and GLP-1, the two incretin hormones: Similarities and differences"
Require: HPLC purity at 99%+ Mass spectrometry confirmation of sequence Independent third-party COA from an accredited lab Lyophilized form with proper storage protocols Excalibur Peptides' GLP-2T is independently verified to 99%+ purity with full COA documentation
A resting heart rate consistently above 100 bpm or blood pressure consistently above 140/90 should prompt immediate clinical reassessment